Take coverage for replacement, as you will have to
purchase at the current price and not at the historical price.
I just can't see how anyone can go in there and
purchase at current prices and think they're going to make good rents not knowing the roadblocks the city put in place to stop you from easily raising rents even in between tenancies.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future
pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the
purchase price for our announced acquisition of Asco on favorable terms or
at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and
purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign
current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP
purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and
price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering
prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or
at all, for new and
current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock
price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
«
At appropriate prices — and that means at a very low multiple of current earnings — we will purchase more papers of the type we like,» Buffett wrote in 201
At appropriate
prices — and that means
at a very low multiple of current earnings — we will purchase more papers of the type we like,» Buffett wrote in 201
at a very low multiple of
current earnings — we will
purchase more papers of the type we like,» Buffett wrote in 2013.
But given the actual market conditions which remain in place, it's difficult to imagine just what investors are hoping for - and what they think their money is actually buying - when they
purchase stocks
at current prices.
After the initial
purchase term, discounted products will renew
at the then -
current renewal list
price.
(d) by causing Retrophin to pay cash to himself, Biestek, and Fernandez so that he would not have to invest $ 731,778 of his own funds in the February PIPE, and by using PIPE proceeds in contravention of the terms of the Securities
Purchase Agreement to fund investments by Shkreli, Biestek and Fernandez, resulting in an additional benefit to Shkreli alone of $ 360,000 in cash and 180,000 Retrophin shares and warrants worth more than $ 5.3 million (
at current market
prices).
First, the stocks I currently own that I consider would like to
purchase more of
at current market
prices.
Market order / market buy / market sell A simple
purchase or sale on an exchange
at the
current price.
Common shares of the Funds are only available for
purchase / sale on the NYSE
at the
current market
price (NYSE - MKT for MFS California Municipal Fund).
Hard rock deposits by and large are not economic
at current spot (or term) uranium
prices, so if you see uranium
at $ 75 or $ 80 per pound in the coming years (I don't),
purchasing shares in hard rock uranium development companies could lead to gains.
Monster Energy Carolina Rebellion General Admission 3 - Day Weekend, 2 - Day, Single Day tickets and 3 - Day Weekend Ticket 4 - Packs are available for
purchase at the
current low ticket
prices at www.CarolinaRebellion.com.
Time for some brutal honesty... this team, as it stands, is in no better position to compete next season than they were 12 months ago, minus the fact that some fans have been easily snowed by the acquisition of Lacazette, the free transfer LB and the release of Sanogo... if you look
at the facts carefully you will see a team that still has far more questions than answers... to better show what I mean by this statement I will briefly discuss the
current state of affairs on a position - by - position basis... in goal we have 4 potential candidates, but in reality we have only 1 option with any real future and somehow he's the only one we have actively tried to get rid of for years because he and his father were a little too involved on social media and he got caught smoking (funny how people still defend Wiltshire under the same and far worse circumstances)... you would think we would want to keep any goaltender that Juventus had interest in, as they seem to have a pretty good history when it comes to that position... as far as the defenders on our
current roster there are only a few individuals whom have the skill and / or youth worthy of our time and / or investment, as such we should get rid of anyone who doesn't meet those simple requirements, which means we should get rid of DeBouchy, Gibbs, Gabriel, Mertz and loan out Chambers to see if last seasons foray with Middlesborough was an anomaly or a prediction of things to come... some fans have lamented wildly about the return of Mertz to the starting lineup due to his FA Cup performance but these sort of pie in the sky meanderings are indicative of what's wrong with this club and it's wishy - washy fan - base... in addition to these moves the club should aggressively pursue the acquisition of dominant and mobile CB to stabilize an all too fragile defensive group that has self - destructed on numerous occasions over the past 5 seasons... moving forward and building on our need to re-establish our once dominant presence throughout the middle of the park we need to target a CDM then do whatever it takes to get that player into the fold without any of the usual nickel and diming we have become famous for (this kind of ruthless haggling has cost us numerous special players and certainly can't help make the player in question feel good about the way their future potential employer feels about them)... in order for us to become dominant again we need to be strong up the middle again from Goalkeeper to CB to DM to ACM to striker, like we did in our most glorious years before and during Wenger's reign... with this in mind, if we want Ozil to be that dominant attacking midfielder we can't keep leaving him exposed to constant ridicule about his lack of defensive prowess and provide him with the proper players in the final third... he was never a good defensive player in Real or with the German National squad and they certainly didn't suffer as a result of his presence on the pitch... as for the rest of the midfield the blame falls squarely in the hands of Wenger and Gazidis, the fact that Ramsey, Ox, Sanchez and even Ozil were allowed to regularly start when none of the aforementioned had more than a year left under contract is criminal for a club of this size and financial might... the fact that we could find money for Walcott and Xhaka, who weren't even guaranteed starters, means that our whole business model needs a complete overhaul... for me it's time to get rid of some serious deadweight, even if it means selling them below what you believe their market value is just to simply right this ship and change the stagnant culture that currently exists... this means saying goodbye to Wiltshire, Elneny, Carzola, Walcott and Ramsey... everyone, minus Elneny, have spent just as much time on the training table as on the field of play, which would be manageable if they weren't so inconsistent from a performance standpoint (excluding Carzola, who is like the recent version of Rosicky — too bad, both will be deeply missed)... in their places we need to bring in some proven performers with no history of injuries... up front, although I do like the possibilities that a player like Lacazette presents, the fact that we had to wait so many years to acquire some true quality
at the striker position falls once again squarely
at the feet of Wenger... this issue highlights the ultimate scam being perpetrated by this club since the arrival of Kroenke: pretend your a small market club when it comes to making
purchases but milk your fans like a big market club when it comes to ticket
prices and merchandising... I believe the reason why Wenger hasn't pursued someone of Henry's quality, minus a fairly inexpensive RVP, was that he knew that they would demand players of a similar ilk to be brought on board and that wasn't possible when the business model was that of a «selling» club... does it really make sense that we could only make a cheeky bid for Suarez, or that we couldn't get Higuain over the line when he was being offered up for half the
price he eventually went to Juve for, or that we've only paid any interest to strikers who were clearly not going to press their
current teams to let them go to Arsenal like Benzema or Cavani... just part of the facade that finally came crashing down when Sanchez finally called their bluff... the fact remains that no one wants to win more than Sanchez, including Wenger, and although I don't agree with everything that he has done off the field, I would much rather have Alexis front and center than a manager who has clearly bought into the Kroenke model in large part due to the fact that his enormous ego suggests that only he could accomplish great things without breaking the bank... unfortunately that isn't possible anymore as the game has changed quite dramatically in the last 15 years, which has left a largely complacent and complicit Wenger on the outside looking in... so don't blame those players who demanded more and were left wanting... don't blame those fans who have tried desperately to raise awareness for several years when cracks began to appear... place the blame
at the feet of those who were well aware all along of the potential pitfalls of just such a plan but continued to follow it even when it was no longer a financial necessity, like it ever really was...
In the past the district has said the amount is inadequate to
purchase any land
at current prices.
THE SHOE:
Current Gucci Shoes, (Gucci), The luxury consignment online retailer, The Real Real, has many fabulous pairs of Gucci shoes for
purchase at very reasonable
prices.
«Up until 31 August 2017, you may
purchase a PlayStation Plus subscription
at the
current price, which will then be added (or «stacked on») to your
current membership period,» an email to members reads.
First, we address the disclosure in fare advertisements of higher
prices, recently introduced by several air carriers, for tickets
purchased at ticket counters or by telephone.1 Second, by this notice, we are advising carriers of the
current policy of the Office of Aviation Enforcement and Proceedings (Aviation Enforcement Office) with regard to the disclosure of «government - approved» surcharges.
A look
at the Fair
Purchase Price shows that the Galant sells slightly below MSRP, although Mitsubishi's current round of incentives will likely lower the price even
Price shows that the Galant sells slightly below MSRP, although Mitsubishi's
current round of incentives will likely lower the
price even
price even more.
Build and
price your own 2018 Cadillac CTS right here at KBB.com to unlock its current Fair Purchase Price, 5 - Year Cost to Own and
price your own 2018 Cadillac CTS right here
at KBB.com to unlock its
current Fair
Purchase Price, 5 - Year Cost to Own and
Price, 5 - Year Cost to Own and more.
Facebook announced their intention to
purchase WhatsApp in February of this year for a cool $ 19 billion (or $ 21.8 billion
at Facebook's
current share
price); a deal that received approval in the United States a few months later in April.
The $ 4.99 is the
current threshold
price at which buyers perceive a good value and are more inclined to
purchase the e-book.
The
current promotion takes the already inexpensive Tab 8
at $ 139 and throws in a $ 40 Best Buy gift card when you
purchase, effectively bringing the
price of the tablet down to just $ 100.
Even
at a
purchase price of $ 1 billion, or close to double the
current market value of BKS, such a
price would be a «rounding error» compared to the market value of a host of internet or media companies looking for a retail presence, with the added benefit being that Barnes & Noble is already in the same fundamental business, namely the distribution of information.
Difficulties happen in the «real economy» when
current assets have a difficult time getting financed, and consumer durable
purchases and capital investments get delayed because financing is not available
at reasonable
prices.
So if I am not the first on that $ 10 BID que, then once $ 10 is reached, there will be shares acquired by some other people first, which will not activate the Limit order, but it will activate the Stop Market buy order, which will result me in
purchasing shares
at the
current market
price.
Broker - dealers,
at their own discretion, may offer a dividend reinvestment service under which additional Units are
purchased in the secondary market
at current market
prices.
To find our qualifying census tracts, income requirements,
purchase price limits,
current rates, debt - to - service ratio and fees, please call our Customer Service Center
at 1-800-522-4167, or visit any Columbia Bank branch.
Discounts: In addition to no - fee dividend reinvestment, some companies also offer DRIPs that allow investors to
purchase stock
at a discount to the
current market
price.
Current Yield: The current yield someone would receive if they made a purchase at prevailing
Current Yield: The
current yield someone would receive if they made a purchase at prevailing
current yield someone would receive if they made a
purchase at prevailing
prices.
As someone who is just a few months from paying off in full a mortgage on a $ 750,000 home (
purchase price, not
current value), I have tried helping friends of mine understand it, but with little success, even when I show them that (in some cases) that we've led remarkably similar lives in terms of our income and expenses (including home) and yet their financial situation is unquestionably horribly inferior to where I (and my wife) are
at.
... [One] should be extra careful when buying into companies and industries that are the
current darlings of the financial community, to be sure that these
purchases are actually warranted — as
at times they well may be — and that he is not paying a fancy
price for something which, because of too favorable interpretation of basic facts is the investment fad of the moment.
The intrinsic value is simply the amount by which the stock's
current price is higher than the call strike - it's the
current discount to the stock's
price that you get if you exercise the call, thereby
purchasing the stock
at the strike
price.
This means he must
purchase the stock
at the
current market
price of $ 45.
Because so many shares are available for
purchase at any one time, a market order will be filled
at an average
price very close to the
current market
price.
And
at the end of the maturity date of your bond, you are paid back your complete principal amount that you invested while
purchasing the bond, irrespective of the
current bond
pricing.
If the futures are above the
current cash
prices at the time of his gold
purchase, he will make a profit on his futures trade, offsetting the higher
price he has to pay for gold from his supplier.
Is it on the original
purchase price of the security or the
current price at time of transfer?
The first thing we think about when we buy a stock is if we'd be happy
purchasing the whole company
at the
current price and holding it for a long time.
Automatic or not, the investor is making a choice to
purchase shares of a stock
at the
current price, yield, etc, and therefore it should be treated as a
purchase.
Companies are usually
purchased at a steep premium over
current share
prices but rarely maintain those levels a year or two after the initial merger and / or acquisition was announced.
They are not interested in selling
at current prices (and apparently can't find anyone who is willing to
purchase their 46 % stake
at above market
prices, strange as that may seem).
Though I'd looked
at RSH a few times over the past year, I only became seriously interested a couple of months ago when I noted that Francis Chou has a significant position (3.6 % of his portfolio) which he had
purchased in the 2nd quarter of 2011 and added to in the final quarter of last year
at prices considerably higher than the then -
current price.
What I can say from a strategic perspective is that 1) I like a
purchase of assets
at historically low
prices, 2) MFC has some expertise in the commodity business so this isn't completely outside their playing field, 3) perhaps, worst case, there could be a strategy to
purchase the assets in bulk
at a distress sale and then sell them off piecemeal for a profit, and 4) while this may be a role of the dice (who knows where gas
prices will be a year from now) MFC is not betting the ranch; the total investment will be about CDN $ 75 million ($ 33 for the outstanding shares, $ 8 million for the warrants, $ 30 million additional investment and I've estimated $ 4 million for transaction costs), or less than 25 % of MFC's
current cash hoard.
Sandstorm's average
purchase price per ounce of gold is US$ 400 so although our margins expand and contract with the gold
price,
at current gold
prices of US$ 1,350 per ounce we are generating strong free cash flow.
Also, most lenders will only lend based on the
current value of the home
at the time of completion regardless of the
purchase price on the contract.
Generally, employees are allowed to
purchased a certain amount of shares per year
at a discount off
current market
prices.
Even if the shares are
purchased at a discount from the
current market
price, no tax is due.
For example, say I built a $ 200k stock portfolio that had an average yield of 5 % (easy
at current prices, even with blue chips), and then
purchased a $ 200k rental property with cash that yielded 7.5 % after all costs (easy to do in the US right now, but also possible in certain Canadian cities like Hamilton or Kitchener).
The net
current assets investment selection criterion calls for the
purchase of stocks which are
priced at 66 % or less of a company's underlying
current assets (cash, receivables and inventory) net of all liabilities and claims senior to a company's common stock (
current liabilities, long - term debt, preferred stock, unfunded pension liabilities).